Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DAL Delta Air Lines	$59.02 -0.7%	$52.25	$34.74 ▼ $69.98	$38.54B	1.56	10.83 million shs	4.30 million shs
GNK Genco Shipping & Trading	$16.51 -1.0%	$14.70	$11.20 ▼ $19.51	$709.18M	1.19	690,097 shs	634,196 shs
SAVE Spirit Airlines	$1.08	$1.66	$1.03 ▼ $3.64	$118.28M	1.37	10.64 million shs	19,128 shs
SQZ SQZ Biotechnologies	$0.03	$0.03	$0.25 ▼ $3.56	$826K	2.34	455,220 shs	N/A

10 Stocks Set to Soar in Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DAL Delta Air Lines	+1.64%	+9.78%	+2.21%	+18.23%	+50.46%
GNK Genco Shipping & Trading	+1.00%	-0.63%	+11.77%	+17.32%	-6.30%
SAVE Spirit Airlines	0.00%	0.00%	0.00%	0.00%	-57.48%
SQZ SQZ Biotechnologies	0.00%	0.00%	0.00%	0.00%	-24.32%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DAL Delta Air Lines	4.7196 of 5 stars	3.5	3.0	2.5	0.6	3.0	2.5	2.5
GNK Genco Shipping & Trading	3.281 of 5 stars	2.6	3.0	2.5	0.0	1.7	0.8	2.5
SAVE Spirit Airlines	0.1234 of 5 stars	0.5	0.0	0.0	0.0	0.6	0.8	1.3
SQZ SQZ Biotechnologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DAL Delta Air Lines	3.00	Buy	$66.21	12.17% Upside
GNK Genco Shipping & Trading	3.20	Buy	$19.33	17.11% Upside
SAVE Spirit Airlines	1.00	Strong Sell	$1.00	-7.41% Downside
SQZ SQZ Biotechnologies	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest GNK, SAVE, DAL, and SQZ Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/7/2025	GNK Genco Shipping & Trading	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$19.00
7/14/2025	DAL Delta Air Lines	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold	$56.00 ➝ $62.00
7/14/2025	DAL Delta Air Lines	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target		$56.00 ➝ $63.00
7/14/2025	DAL Delta Air Lines	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$55.00 ➝ $66.00
7/11/2025	DAL Delta Air Lines	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$72.00
7/11/2025	DAL Delta Air Lines	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Positive ➝ Positive	$65.00
7/11/2025	DAL Delta Air Lines	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
7/11/2025	DAL Delta Air Lines	BNP Paribas Exane Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform	$58.00 ➝ $70.00
7/11/2025	DAL Delta Air Lines	Bernstein Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform	$60.00 ➝ $66.00
7/11/2025	DAL Delta Air Lines	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight	$66.00 ➝ $72.00
7/11/2025	DAL Delta Air Lines	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$62.00 ➝ $65.50

(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DAL Delta Air Lines	$61.93B	0.62	$10.18 per share	5.80	$26.71 per share	2.21
GNK Genco Shipping & Trading	$423.02M	1.68	$3.49 per share	4.73	$20.79 per share	0.79
SAVE Spirit Airlines	$5.36B	0.02	N/A	N/A	$10.39 per share	0.10
SQZ SQZ Biotechnologies	$18.16M	0.05	N/A	N/A	$1.94 per share	0.01

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DAL Delta Air Lines	$3.46B	$6.90	8.55	7.13	1.82	7.24%	24.86%	5.01%	10/9/2025 (Estimated)
GNK Genco Shipping & Trading	$76.40M	$0.34	48.55	14.61	N/A	4.40%	1.40%	1.23%	N/A
SAVE Spirit Airlines	-$447.46M	-$6.18	N/A	N/A	N/A	-13.20%	-57.87%	-6.51%	N/A
SQZ SQZ Biotechnologies	-$79.46M	-$2.61	N/A	N/A	N/A	-369.96%	-119.83%	-59.90%	N/A

Latest GNK, SAVE, DAL, and SQZ Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/6/2025	Q2 2025	GNK Genco Shipping & Trading	-$0.15	-$0.14	+$0.01	-$0.16	$50.19 million	$46.90 million
7/10/2025	Q2 2025	DAL Delta Air Lines	$2.01	$2.10	+$0.09	$3.27	$16.16 billion	$15,507,000.00 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DAL Delta Air Lines	$0.75	1.27%	N/A	10.87%	1 Years
GNK Genco Shipping & Trading	$0.60	3.63%	N/A	176.47%	N/A
SAVE Spirit Airlines	N/A	N/A	N/A	N/A	N/A
SQZ SQZ Biotechnologies	N/A	N/A	N/A	N/A	N/A

Latest GNK, SAVE, DAL, and SQZ Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/7/2025	GNK Genco Shipping & Trading	quarterly	$0.15	3.7%	8/18/2025	8/18/2025	8/25/2025
6/19/2025	DAL Delta Air Lines	quarterly	$0.1875	1.58%	7/31/2025	7/31/2025	8/21/2025
5/20/2025	GNK Genco Shipping & Trading		$0.15	4.28%	5/22/2025	5/23/2025	5/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DAL Delta Air Lines	0.74	0.38	0.33
GNK Genco Shipping & Trading	0.10	1.63	1.20
SAVE Spirit Airlines	3.86	0.94	0.94
SQZ SQZ Biotechnologies	N/A	3.50	3.50

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DAL Delta Air Lines	69.93%
GNK Genco Shipping & Trading	58.62%
SAVE Spirit Airlines	58.73%
SQZ SQZ Biotechnologies	38.51%

Insider Ownership

Company	Insider Ownership
DAL Delta Air Lines	0.88%
GNK Genco Shipping & Trading	2.37%
SAVE Spirit Airlines	0.72%
SQZ SQZ Biotechnologies	16.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DAL Delta Air Lines	100,000	652.95 million	647.20 million	Optionable
GNK Genco Shipping & Trading	1,010	42.96 million	41.94 million	Not Optionable
SAVE Spirit Airlines	13,167	109.52 million	108.73 million	Optionable
SQZ SQZ Biotechnologies	1,620	29.49 million	24.77 million	Not Optionable

GNK, SAVE, DAL, and SQZ Headlines

Recent News About These Companies

Serica Energy reveals impact of Triton downtime, eyes volume recovery â€œsoonâ€

August 5, 2025 | proactiveinvestors.co.uk

SQZB SQZ Biotechnologies Company - Seeking Alpha

July 9, 2025 | seekingalpha.com

Serica Energy shares drop as Triton suspended until mid-March

February 18, 2025 | proactiveinvestors.co.uk

Serica Energy says 2025 outlook is â€˜promising'

January 21, 2025 | proactiveinvestors.co.uk

Serica Energy expects to remedy â€œclearly disappointingâ€ recent production performance

January 7, 2025 | proactiveinvestors.co.uk

SQZ Biotechnologies Co Ordinary Shares

December 23, 2024 | morningstar.comM

Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures

December 19, 2024 | finance.yahoo.com

Global Short-Acting Insulin Market is Expected to Cross ~USD 9 Billion by 2030 | DelveInsight

September 5, 2024 | prnewswire.co.ukP

STEMCELL Launches Novel Cell-Engineering CellPore™ Transfection System

August 1, 2024 | valdostadailytimes.comV

What is the price tag to keep the biotech engine humming in Massachusetts?

July 23, 2024 | msn.com

SQZ Biotechnologies Company (SQZB)

May 22, 2024 | finance.yahoo.com

Sqz Bio (SQZB) Earnings Dates & Reports

May 8, 2024 | investing.com

VC funding update: who raised money in March?

April 1, 2024 | bizjournals.com

SQZ, Portal founder Armon Sharei on starting over in biotech

March 26, 2024 | biopharmadive.comB

Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC

March 19, 2024 | finance.yahoo.com

SQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell

March 1, 2024 | fiercebiotech.comF

Rx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and more

February 16, 2024 | mmm-online.comM

SQZB SQZ Biotechnologies Company

December 28, 2023 | seekingalpha.com

SQZ Biotechnologies Co Ordinary Shares SQZB

December 12, 2023 | morningstar.comM

SQZ founder Armon Sharei opens Portal to to simplify intracellular delivery

December 12, 2023 | fiercebiotech.comF

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

GNK, SAVE, DAL, and SQZ Company Descriptions

Delta Air Lines NYSE:DAL

$59.02 -0.40 (-0.67%)

Closing price 03:59 PM Eastern

Extended Trading

$59.11 +0.09 (+0.15%)

As of 05:46 PM Eastern

Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its domestic network centered on core hubs in Atlanta, Minneapolis-St. Paul, Detroit, and Salt Lake City, as well as coastal hub positions in Boston, Los Angeles, New York-LaGuardia, New York-JFK, and Seattle; and international network centered on hubs and market presence in Amsterdam, Bogota, Lima, Mexico City, London-Heathrow, Paris-Charles de Gaulle, Sao Paulo, Seoul-Incheon, and Tokyo. The company sells its tickets through various distribution channels, including delta.com and the Fly Delta app; acts as a reservations specialists; and operates online travel and traditional brick and mortar agencies. It also provides aircraft maintenance and engineering support, repair, and overhaul services; and vacation packages to third-party consumers. The company operates through a fleet of approximately 1,273 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is based in Atlanta, Georgia.

Genco Shipping & Trading NYSE:GNK

$16.51 -0.16 (-0.97%)

Closing price 03:59 PM Eastern

Extended Trading

$16.30 -0.21 (-1.26%)

As of 05:22 PM Eastern

Genco Shipping & Trading Ltd. is an international ship owning company, which engages in the transportation of iron ore, coal, grain, bauxite, steel products, and other drybulk cargoes. It operates through the Major Bulk and Minor Bulk segments. The Major Bulk segment focuses on Capesize vessels. The Minor Bulk segment consists of Ultramax and Supramax vessels. The company was founded on September 27, 2004 and is headquartered in New York, NY.

Spirit Airlines NYSE:SAVE

Spirit Airlines, Inc. provides airline services. The company also offers hotels and rental cars services. It serves 93 destinations in 15 countries in the United States, Latin America, and the Caribbean. As of December 31, 2023, the company operated a fleet of 205 Airbus single-aisle aircraft. The company was formerly known as Clippert Trucking Company and changed its name to Spirit Airlines, Inc. in 1992. Spirit Airlines, Inc. was incorporated in 1964 and is headquartered in Miramar, Florida.

SQZ Biotechnologies NYSE:SQZ

$0.03 0.00 (0.00%)

As of 08/13/2025

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time